No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 5, 2006, Pages 356-360

  Pask, Rebecca ^a   Cooper, Jason D ^a   Walker, Neil M ^a   Nutland, Sarah ^a   Hutchings, Jayne ^a   Dunger, David B ^b   Nejentsev, Sergey ^a   Todd, John A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Association; Catalase; Genetic; Genotype; Polymorphisms; Type 1 diabetes

Indexed keywords

CATALASE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETOGENESIS; FAMILY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; POPULATION GENETICS; PRIORITY JOURNAL; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; UNITED STATES;

BASE SEQUENCE; CASE-CONTROL STUDIES; CATALASE; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 33748994275     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.628     Document Type: Article

References (22)

1. Chistiakov DA, Savost'anov KV, Turakulov RI, et al. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab Res Rev 2004; 20: 219-224.
2. Gurgul E, Lortz S, Tiedge M, et al. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 2004; 53: 2271-2280.
3. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998; 55: 1139-1149.
4. Bain SC, Todd JA, Barnett AH. The British diabetic association-Warren repository. Autoimmunity 1990; 7: 83-85.
5. Patterson CC, Carson DJ, Hadden DR. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 1996; 39: 1063-1069.
6. Undlien DE, Akselsen HE, Joner G, et al. No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet 1995; 57: 1511-1514.
7. Lernmark A. Human cell lines from families available for diabetes research. Diabetologia 1991; 34: 61.
8. Ionescu-Tirgoviste C, Guja C, Herr M, et al. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes. Diabetologia 2001; 3(Suppl): B60-B66.
9. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
10. Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53: 3020-3023.
11. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
12. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
13. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980; 32: 5-338.
15. Clayton D, Hills M. Statistical Models in Epidemiology Oxford University Press, Oxford.
16. Vella A, Cooper JD, Lowe CE, et al. Localisation of a type 1 diabetes locus in the IL2RA/CD25 region using tag single nucleotide polymorphisms. Am J Hum Genet 2005 76(5): 773-779.
17. Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002; 15: 62-66.
18. EI-Sohemy A, Cornelis MC, Park YW, Bae SC. Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int 2005; 1-5.
19. Wang WJS, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6: 109-118.
20. Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434-442.
21. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst 2004; 96: 421-423.
22. Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005; 366: 1121-1131.